Subscribe
steve-debenport-1
steve-debenport-1 / iStockphoto.com
8 September 2017Europe

Illumina files for patent infringement over prenatal test

Genetic sequencing company Illumina has filed a patent infringement suit against Premaitha Health, a molecular diagnostics company, in the English High Court.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Illumina to pay Enzo $21m to end patent dispute
14 July 2016   Illumina has reached a settlement with Enzo Life Sciences, bringing an end to allegations that it infringed a DNA detection patent.
Europe
Prenatal test infringes Illumina patents, rules English High Court
22 November 2017   A prenatal test sold by molecular diagnostics company Premaitha Health infringes patents owned by genetic sequencing firm Illumina, a UK court has ruled.
Americas
Illumina accused of fraud in DNA tech patents dispute
12 January 2021   Illumina tried to secure its control over the DNA sequencing technology market by violating antitrust law, according to a suit by BGI Americas and two of its subsidiaries, at the US Court for the District Court of San Francisco.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

More on this story

Americas
Illumina accused of fraud in DNA tech patents dispute
12 January 2021   Illumina tried to secure its control over the DNA sequencing technology market by violating antitrust law, according to a suit by BGI Americas and two of its subsidiaries, at the US Court for the District Court of San Francisco.
Europe
Prenatal test infringes Illumina patents, rules English High Court
22 November 2017   A prenatal test sold by molecular diagnostics company Premaitha Health infringes patents owned by genetic sequencing firm Illumina, a UK court has ruled.
Americas
Illumina to pay Enzo $21m to end patent dispute
14 July 2016   Illumina has reached a settlement with Enzo Life Sciences, bringing an end to allegations that it infringed a DNA detection patent.

More on this story

Americas
Illumina accused of fraud in DNA tech patents dispute
12 January 2021   Illumina tried to secure its control over the DNA sequencing technology market by violating antitrust law, according to a suit by BGI Americas and two of its subsidiaries, at the US Court for the District Court of San Francisco.
Europe
Prenatal test infringes Illumina patents, rules English High Court
22 November 2017   A prenatal test sold by molecular diagnostics company Premaitha Health infringes patents owned by genetic sequencing firm Illumina, a UK court has ruled.
Americas
Illumina to pay Enzo $21m to end patent dispute
14 July 2016   Illumina has reached a settlement with Enzo Life Sciences, bringing an end to allegations that it infringed a DNA detection patent.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility